Learning Objectives
Upon completion of this activity, participants should be able to:
- Explain the relative merits of anthracycline-based chemotherapy and nonanthracycline-based therapy to patients with breast cancer
- Discuss with patients how estrogen receptor status, progesterone receptor status, and HER2 status relates to breast cancer outcomes
- Describe key findings of breast cancer trials demonstrating patient responses to anthracycline or nonanthracyline-based regimens
CCO Virtual Presentations combine slides with audio commentary by our esteemed faculty. Complete the CME posttest and evaluation after watching the presentation.